Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2023

18.03.2023 | Pathology

Clinical features and factors affecting prognosis and partial deterioration of ocular papilloma: a retrospective study of 298 cases

verfasst von: Huan Jian, Weimin He

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to analyze the clinicopathological features of ocular papilloma, a common benign tumor, and the risk factors related to its recurrence and partial deterioration.

Methods

We collected and analyzed the clinical information of 298 patients (51.68% males) with mean age of 41.54 ± 21.95 years, in the ophthalmology department of the West China Hospital. Clinical and pathological factors that might be related to papilloma recurrence and partial deterioration were studied.

Results

The top three papilloma sites were bulbar conjunctiva, eyelid skin and palpebral conjunctiva. Moreover, 3.59% of lesions presented a malignant transformation, and 16.28% of patients had one or more recurrences after an average follow-up of 4.47 years. The multivariate logistic regression model showed that multiple lesions were a risk factor for recurrence (p = 0.022, OR = 3.088, 95% CI: 1.180–8.079), while cryotherapy decreased the recurrence risk (p = 0.044, OR = 0.364, 95% CI: 0.136–0.972). Additionally, elderly patients and lesions on the corneal limbus or cornea had a higher risk of malignant transformation (p = 0.004 and 0.01, OR = 1.086 and 7.827, 95% CI: 1.027–1.150 and 1.629–37.596, respectively).

Conclusion

Ocular papilloma usually occurs in middle-aged and young patients, with no significant gender differences. Older patients and lesions on the corneal limbus or cornea are risk factors for partial malignant transformation. Finally, multiple lesions were a risk factor for recurrence, and cryotherapy reduced the recurrence rate.
Literatur
1.
Zurück zum Zitat Yhk L, Yef Y, Cn R et al (2002) The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. Cornea 21:838–839CrossRef Yhk L, Yef Y, Cn R et al (2002) The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. Cornea 21:838–839CrossRef
2.
Zurück zum Zitat Lassalle S, Maschi C, Caujolle J-P et al (2017) Inverted conjunctival papilloma: a certainly underestimated high-risk lesion for carcinomatous transformation—a case report. Can J Ophthalmol 52:e30–e31CrossRefPubMed Lassalle S, Maschi C, Caujolle J-P et al (2017) Inverted conjunctival papilloma: a certainly underestimated high-risk lesion for carcinomatous transformation—a case report. Can J Ophthalmol 52:e30–e31CrossRefPubMed
4.
Zurück zum Zitat Theotoka D, Morkin MI, Galor A et al (2019) Update on Diagnosis and Management of Conjunctival Papilloma. Eye Vis (Lond) 6:18CrossRefPubMed Theotoka D, Morkin MI, Galor A et al (2019) Update on Diagnosis and Management of Conjunctival Papilloma. Eye Vis (Lond) 6:18CrossRefPubMed
5.
Zurück zum Zitat Moyer AB, Roberts J, Olsen RJ et al (2018) Human Papillomavirus-Driven Squamous Lesions: High-Risk Genotype Found in Conjunctival Papillomas, Dysplasia, and Carcinoma. Am J Dermatopathol 40:486–490CrossRefPubMed Moyer AB, Roberts J, Olsen RJ et al (2018) Human Papillomavirus-Driven Squamous Lesions: High-Risk Genotype Found in Conjunctival Papillomas, Dysplasia, and Carcinoma. Am J Dermatopathol 40:486–490CrossRefPubMed
6.
Zurück zum Zitat Asadi-Amoli F, Ghanadan A (2015) Survey of 274 patients with conjunctival neoplastic lesions in Farabi Eye Hospital, Tehran 2006–2012. J Curr Ophthalmol 27:37–40CrossRefPubMedPubMedCentral Asadi-Amoli F, Ghanadan A (2015) Survey of 274 patients with conjunctival neoplastic lesions in Farabi Eye Hospital, Tehran 2006–2012. J Curr Ophthalmol 27:37–40CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ganapathy PS, Plesec T, Singh AD (2017) Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus). Am J Ophthalmol Case Rep 6:1–3CrossRefPubMedPubMedCentral Ganapathy PS, Plesec T, Singh AD (2017) Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus). Am J Ophthalmol Case Rep 6:1–3CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sjo N, Heegaard S, Prause JU (2000) Conjunctival papilloma. A histopathologically based retrospective study. Acta Ophthalmol Scand 78:663–666CrossRefPubMed Sjo N, Heegaard S, Prause JU (2000) Conjunctival papilloma. A histopathologically based retrospective study. Acta Ophthalmol Scand 78:663–666CrossRefPubMed
9.
Zurück zum Zitat Huang Y-M, Huang Y-Y, Yang H-Y et al (2018) Conjunctival papilloma: Clinical features, outcome, and factors related to recurrence. Taiwan J Ophthalmol 8:15–18CrossRefPubMedPubMedCentral Huang Y-M, Huang Y-Y, Yang H-Y et al (2018) Conjunctival papilloma: Clinical features, outcome, and factors related to recurrence. Taiwan J Ophthalmol 8:15–18CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kalogeropoulos C, Koumpoulis I, Papadiotis E et al (2012) Squamous cell papilloma of the conjunctiva due to human papillomavirus (HPV): presentation of two cases and review of literature. Clin Ophthalmol 6:1553–1561CrossRefPubMedPubMedCentral Kalogeropoulos C, Koumpoulis I, Papadiotis E et al (2012) Squamous cell papilloma of the conjunctiva due to human papillomavirus (HPV): presentation of two cases and review of literature. Clin Ophthalmol 6:1553–1561CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Falco LA, Gruosso PJ, Skolnick K et al (2007) Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma. Optometry 78:162–166CrossRefPubMed Falco LA, Gruosso PJ, Skolnick K et al (2007) Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma. Optometry 78:162–166CrossRefPubMed
12.
Zurück zum Zitat Yazu H, Dogru M, Miyauchi J et al (2018) Association of Epithelial Atypia With Recurrence After Surgical Excision in Conjunctival Papilloma. Eye Contact Lens 44(Suppl 1):S77–S81CrossRefPubMed Yazu H, Dogru M, Miyauchi J et al (2018) Association of Epithelial Atypia With Recurrence After Surgical Excision in Conjunctival Papilloma. Eye Contact Lens 44(Suppl 1):S77–S81CrossRefPubMed
13.
Zurück zum Zitat Ingvild R, Christian SN, Hansen BJ et al (2019) Inverted papilloma of the conjunctiva. BMJ Open Ophthalmol 4:e000193CrossRef Ingvild R, Christian SN, Hansen BJ et al (2019) Inverted papilloma of the conjunctiva. BMJ Open Ophthalmol 4:e000193CrossRef
14.
Zurück zum Zitat Smetana K Jr, Lacina L, Szabo P et al (2016) Ageing as an Important Risk Factor for Cancer. Anticancer Res 36:5009–5017CrossRefPubMed Smetana K Jr, Lacina L, Szabo P et al (2016) Ageing as an Important Risk Factor for Cancer. Anticancer Res 36:5009–5017CrossRefPubMed
15.
Zurück zum Zitat Newton R, Ferlay J, Reeves G et al (1996) Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 347:1450–1451CrossRefPubMed Newton R, Ferlay J, Reeves G et al (1996) Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 347:1450–1451CrossRefPubMed
16.
Zurück zum Zitat Kaliki S, Arepalli S, Shields CL et al (2013) Conjunctival papilloma: features and outcomes based on age at initial examination. JAMA Ophthalmol 131:585–593CrossRefPubMed Kaliki S, Arepalli S, Shields CL et al (2013) Conjunctival papilloma: features and outcomes based on age at initial examination. JAMA Ophthalmol 131:585–593CrossRefPubMed
Metadaten
Titel
Clinical features and factors affecting prognosis and partial deterioration of ocular papilloma: a retrospective study of 298 cases
verfasst von
Huan Jian
Weimin He
Publikationsdatum
18.03.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 8/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-023-06035-y

Weitere Artikel der Ausgabe 8/2023

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.